Citigroup
TTHI

Citigroup’s TRANSITION THERAPEUTICS INC (CANADA) TTHI Stock Holding History

Citigroup’s Portfolio TTHI Stock Details TTHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,478
Closed -$2K – 7962
2016
Q1 		$2K Buy
1,478
+960
+185% +$1.11K ﹤0.01% 7260
2015
Q4 		$1K Buy
518
+165
+47% +$313 ﹤0.01% 7505
2015
Q3 		$1K Buy
+353
New +$751 ﹤0.01% 7328
2013
Q4 		– Sell
-128
Closed -$1K – 7504
2013
Q3 		$1K Sell
128
-264
-67% -$1.04K ﹤0.01% 6771
2013
Q2 		$1K Buy
+392
New +$1.11K ﹤0.01% 6719

Other funds holding TTHI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
NC
NBW Capital Boston, Massachusetts $464M AUM 21.25% 1-Year Est. Return
KAM
Kassirer Asset Management Toronto, Ontario, Canada $4.07M AUM 49.71% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Citigroup's TTHI Position: Q2 2016 in Review

Citigroup sold out of TRANSITION THERAPEUTICS INC (CANADA) (TTHI) in Q2 2016, closing a stake of 1,478 shares — an estimated $2K sold.

Citigroup first reported a position in TTHI in Q2 2013 and held it in 5 quarters. The position peaked at $2K in Q1 2016. 20 funds tracked by Wall St. Rank hold TTHI as of Q2 2016.

  • Citigroup reported no remaining TRANSITION THERAPEUTICS INC (CANADA) position as of Q2 2016 after selling out during the quarter.
  • Citigroup sold 1,478 TRANSITION THERAPEUTICS INC (CANADA) shares in Q2 2016, an estimated $2K.
  • Citigroup first reported a position in TRANSITION THERAPEUTICS INC (CANADA) in Q2 2013 and held it in 5 quarters.
  • Citigroup's TRANSITION THERAPEUTICS INC (CANADA) position peaked at $2K in Q1 2016.
  • 20 funds tracked by Wall St. Rank held TRANSITION THERAPEUTICS INC (CANADA) as of Q2 2016.

Based on Citigroup's 13F filing for Q2 2016, filed 12 Aug 2016.